Product Information
FONDAPARINUX 5 MG/0.4 ML SYR is a generic product labeled by Eugia US LLC, priced at $55.3125 per ML under NDC 55150023110. Its NADAC has been published 70 times since May 21, 2025.
FDA first approved this application on Dec 26, 2017. Its Orange Book therapeutic-equivalence code is AP.
Strength
5 mg/.4mL
Manufacturer
Eugia US LLCNDC
55150023110
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
9/17/2025
Active Ingredients
FONDAPARINUX SODIUMApproval Type
Generic (ANDA)
FDA Application
ANDA206918FDA Approved
12/26/2017
TE Code
AP
On Market Since
12/26/2017
Pharmacological Classes
Price Statistics
The NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has been published 70 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $55.3125 per ML |
|---|---|
| All-time high | $55.3125 (Sep 16, 2026) |
| All-time low | $55.3125 (May 21, 2025) |
| 52-week high | $55.3125 |
| 52-week low | $55.3125 |
| Median price | $55.3125 |
| Average price | $55.3125 |
| Largest weekly change | 0.0% (May 28, 2025) |
| Weeks tracked | 70 |
| Tracking since | May 21, 2025 |
1W
N/A
1M
0.0%
3M
0.0%
6M
0.0%
1Y
0.0%
3Y
N/A
5Y
N/A
All
0.0%
Last surveyed Sep 16, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the FONDAPARINUX SODIUM market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FONDAPARINUX SODIUM market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Factor Xa Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FONDAPARINUX 5 MG/0.4 ML SYR?
The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 5 MG/0.4 ML SYR, manufactured by Eugia US LLC, is $55.3125 per ML (NDC 55150023110), effective Sep 16, 2026.
How has the price of FONDAPARINUX 5 MG/0.4 ML SYR changed over time?
Over the history we have for it, the NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has held within roughly two percent of its current level. It has been tracked across 70 weekly CMS publications since May 21, 2025.
What are the highest and lowest recorded NADAC prices for FONDAPARINUX 5 MG/0.4 ML SYR?
Since May 21, 2025, the NADAC for FONDAPARINUX 5 MG/0.4 ML SYR has ranged from a low of $55.3125 (May 21, 2025) to a high of $55.3125 (Sep 16, 2026), with a median of $55.3125 per ML.
Are there cheaper alternatives to FONDAPARINUX 5 MG/0.4 ML SYR?
No other NADAC-published product currently shares the active ingredient and strength of FONDAPARINUX 5 MG/0.4 ML SYR in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FONDAPARINUX 5 MG/0.4 ML SYR?
FONDAPARINUX 5 MG/0.4 ML SYR (NDC 55150023110) is labeled by Eugia US LLC, and CMS classifies it as a generic product.